In different types of cancers, such as steroid hormone-driven cancers (breast and prostate cancers), the amplification/overexpression of STARD3 could promote intra-neoplastic autonomous steroidogenesis and contribute primarily to the development of the malignancy. Here, STARD3 is linked to Familial prostate cancer.